Prostaglandin E2 content in herniated lumbar disc disease

Spine (Phila Pa 1976). 1996 Jul 15;21(14):1653-5; discussion 1655-6. doi: 10.1097/00007632-199607150-00007.

Abstract

Study design: A prospective series of biochemical assays for prostaglandin E2 content in symptomatic herniated lumbar disc specimens.

Objectives: To help clarify the pathogenesis of lumbar radiculopathy.

Summary of background data: Three recent studies have shown elevated levels of prostaglandin E2 in intervertebral disc herniations. None of these studies correlated symptoms with prostaglandin E2 levels.

Methods: Twenty-four disrupted disc samples were purified by a standard solid phase extraction method and analyzed for prostaglandin E2 with an enzyme-linked immunosorbent assay. Clinical and anatomic correlations were sought with analysis of variance and t test.

Results: Sequestered discs tended to be associated with a higher prostaglandin E2 content than extruded discs, which in turn, tended to be associated with higher prostaglandin E2 content than protruded ones. A positive straight leg raising test appeared to be associated with a higher prostaglandin E2 content than a negative test.

Conclusions: Prostaglandin E2 appears to mediate some of the inflammatory effects of lumbar disc herniation. An intact anulus may provide some protection against this stimulus.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Dinoprostone / biosynthesis*
  • Humans
  • Intervertebral Disc / metabolism*
  • Intervertebral Disc / pathology
  • Intervertebral Disc Displacement / metabolism*
  • Intervertebral Disc Displacement / pathology
  • Leg / physiopathology
  • Low Back Pain / etiology
  • Lumbar Vertebrae / metabolism*
  • Lumbar Vertebrae / pathology
  • Sciatica / etiology

Substances

  • Dinoprostone